Brenig Therapeutics
Operator of a drug development company intended to utilize an AI/ML approach through clinical candidates across multiple therapeutic areas. The company is redefining the frontier of aging science with...
Valuation
$0
Share Price
N/A
Total Raised
$73M
Last Round
N/A